GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Jumpcan Pharmaceutical Co Ltd (SHSE:600566) » Definitions » Tax Provision

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Tax Provision : ¥-502 Mil (TTM As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Hubei Jumpcan Pharmaceutical Co Tax Provision?

Hubei Jumpcan Pharmaceutical Co's tax provision for the three months ended in Mar. 2024 was ¥-143 Mil. Its tax provision for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-502 Mil.

Hubei Jumpcan Pharmaceutical Co Tax Provision Historical Data

The historical data trend for Hubei Jumpcan Pharmaceutical Co's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Jumpcan Pharmaceutical Co Tax Provision Chart

Hubei Jumpcan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -270.17 -206.29 -233.22 -336.20 -470.03

Hubei Jumpcan Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -111.35 -109.06 -91.79 -157.83 -143.00

Hubei Jumpcan Pharmaceutical Co Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-502 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Jumpcan Pharmaceutical Co Ltd (SHSE:600566) » Definitions » Tax Provision
Comparable Companies
SHSE:600079 SZSE:000513 SZSE:002603 SHSE:600518 SHSE:600521 SZSE:000661 SZSE:000423 SHSE:600329 SHSE:600380 SZSE:002262 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
Heights Garden Road, Room 602 fashion, Shashi District, Jingzhou, Hubei, CHN
Website
http://www.jumpcan.com
Hubei Jumpcan Pharmaceutical Co Ltd engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based on Chinese traditional medicines, and Chinese medicine health products in China. It offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatric. The company also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.
Executives
Cao Wei Directors, senior managers
Zhou Qi Hua senior management
Huang Qu Rong Director
Yan Hong Quan senior management
Shi Wen Zheng senior management
Zhang Jian Min Director
Cao Long Xiang Director
Yan Yue Hua Director

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Headlines

No Headlines